News

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...
Tinygemsbreaks Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured In Networknewswire Spotlight On Genetic Medicines
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled“ ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...
TipRanks on MSN2d
Why Is Calidi Biotherapeutics Stock (CLDI) Up 170% Today?
Calidi Biotherapeutics stock was up 171.84% in pre-market trading on Wednesday, following a 39.47% rally yesterday. However, ...
Benzinga.com3d
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
Calidi Biotherapeutics Inc. CLDI stock surged by 39.47% in the after-hours trading session on Tuesday. The stock price ...
Morningstar1d
Calidi Biotherapeutics Inc. (NYSE American: CLDI ... - Morningstar
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire ("NNW ...
Biomednewsbreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Raises $4.6 Million Through Warrant Exercise Agreement
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a ...
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...